Cerecor

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Cerecor and buy or sell other stocks, ETFs, and their options commission-free!

About CERC

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. 

CEO
Garry Arthur Neil, MD
CEOGarry Arthur Neil, MD
Employees
23
Employees23
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2011
Founded2011
Employees
23
Employees23

CERC Key Statistics

Market cap
30.68M
Market cap30.68M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
—
Dividend yield—
Average volume
80.41K
Average volume80.41K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$17.49
52 Week high$17.49
52 Week low
$4.15
52 Week low$4.15
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.